AstraZeneca to acquire Alexion in $39 billion deal

Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares per Alexion share.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37bN6ZK
via IFTTT